Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Olopatadine Nasal Spray
NCT00578331Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olopatadine in perennial allergic rhinitis (PAR), sponsored by Alcon Inc.. Started Dec 2006; status: completed.
02
Drugs
olopatadine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00578331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578331.